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Abstract
When analysing in vitro data, growth kinetics of influenza strains are often
compared by computing their growth rates, which are sometimes used as proxies
for fitness. However, analogous to mechanistic epidemic models, the growth rate
can be defined as a function of two parameters: the basic reproduction number (the
average number of cells each infected cell infects) and the mean generation time
(the average length of a replication cycle). Using a mechanistic model, previously
published data from experiments in human lung cells, and newly generated data,
we compared estimates of all three parameters for six influenza A strains. Using
previously published data, we found that the two human-adapted strains (pre-2009
seasonal H1N1, and pandemic H1N1) had a lower basic reproduction number,
shorter mean generation time and slower growth rate than the two avian-adapted
strains (H5N1 and H7N9). These same differences were then observed in data
from new experiments where two strains were engineered to have different internal
proteins (pandemic H1N1 and H5N1), but the same surface proteins (PR8),
confirming our initial findings and implying that differences between strains were
driven by internal genes. Also, the model predicted that the human-adapted strains
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underwent more replication cycles than the avian-adapted strains by the time of
peak viral load, potentially accumulating mutations more quickly. These results
suggest that the in vitro reproduction number, generation time and growth rate
differ between human-adapted and avian-adapted influenza strains, and thus could
be used to assess host adaptation of internal proteins to inform pandemic risk
assessment.
2
Introduction
Transmission experiments conducted using mammalian models are used to assess
the pandemic risk of influenza virus strains currently circulating in animal
reservoirs [Cox et al., 2014]. However, the cost and animal housing requirements
for these experiments leads to small sample sizes [Nishiura et al., 2013] and
scaling problems for systematic assessment across a large panel of strains. Animal
experiment protocols are difficult to standardise, further complicating cross-study
comparisons [Belser et al., 2018]. On the other hand, in vitro assays can be used to
measure several factors affecting human adaptation of influenza strains, such as
haemagglutinin receptor binding specificity, haemagglutinin pH of activation, and
polymerase complex efficiency [Lipsitch et al., 2016]. However, methods to
synthesise information from these assays and estimate strain-specific pandemic
risk are lacking. If we could identify predictors for human adaptation which are
quantitatively comparable between strains and can be measured using
high-thoroughput assays, then their routine estimation would be highly informative
for public health decision making. In this study, we propose three such predictors:
the basic reproduction number, the mean generation time, and the initial growth
rate. These parameters have been widely used to characterise the dynamics of
epidemics, but only the last of these is commonly used in experimental virology to
characterise in vitro/within-host growth kinetics.
The initial growth rate is often directly interpreted in studies of virus evolution as a
measure of in vitro or within-host
fitness [Sanjua´n, 2010, Lyons and Lauring, 2018]. In epidemiological studies, the
initial growth rate can be expressed as a function of two parameters: the basic
reproduction number and the mean generation time. Each of these concepts can
also be applied to the in vitro or within-host context.
The basic reproduction number in an epidemiological context is the mean number
of secondary infections due to an initial infected individual in an otherwise
susceptible population. The cellular-level equivalent is the mean number of
secondary infected cells due to an initial infected cell in an otherwise susceptible
cell population. Studies have estimated the basic cellular reproduction number for
different pathogens, such as
HIV/SHIV [Iwami et al., 2012, Iwami et al., 2015, Iwanami et al., 2017], influenza
A virus [Baccam et al., 2006] and rotavirus [Gonza´lez-Parra et al., 2018]. A
limited number of these studies have directly compared the basic reproduction
number between different influenza or SHIV strains, as a measure of relative
fitness [Mitchell et al., 2011, Iwanami et al., 2017, Farrukee et al., 2018].
In an epidemiological context, the generation time is the time between infection of
an individual and infection of a secondary case. The cellular-level equivalent is the
time between infection of a cell and infection of a secondary cell. Since a single
cell will infect many secondary cells, this time varies between pairs of primary and
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secondary infected cells. A useful summary statistic for the distribution of these
times is the mean generation time averaged over all secondary cells, in an
otherwise susceptible cell population. The mean generation time is an important
parameter in models of pathogen
evolution [Russell et al., 2012, Fonville, 2015, Illingworth, 2015,
Nene´ et al., 2018, Geoghegan et al., 2016, Reperant et al., 2015]. In the context of
HIV, a mean generation time on the order of days has been linked to the rapid
evolution of drug resistance, necessitating combination antiretroviral
therapy [Perelson et al., 1996]. Although mechanistic models have been used to
quantify the mean generation time for HIV
[Perelson et al., 1996, Iwami et al., 2015, Althaus et al., 2009, Dixit et al., 2004],
the effects of between-strain differences on the dynamics of infection and
evolution are not well studied.
This study aims to highlight the utility of the basic reproduction number and mean
generation time in addition to the initial growth rate in considering the dynamics of
an acute infection. We show that these three quantities (which we refer to
collectively as cellular infection parameters) differ significantly between influenza
virus strains. These differences correlate with different degrees of human
adaptation, suggesting that these cellular infection parameters may be useful
metrics to summarise biological differences. Importantly, although the parameters
correlate with the in vivo characteristic of human adaptation, they can be estimated
using simple in vitro assays. We then use simulations to show the impact of these
parameters on the number of replication rounds leading up to peak shedding; faster
initial growth rates lead to a greater proportion of virions that were the product of
several replication rounds. We anticipate that strain differences in the number of
replication cycles changes the accumulation rate of multiple mutations within a
single infection, with consequences for the pace of virus evolution.
4
Results
We used a mechanistic model to characterise the in vitro growth of four wild-type
(WT) influenza A strains. These strains were A/Canada/RV733/2003 (a
human-adapted strain, henceforth referred to as sH1N1-WT),
A/Mexico/INDRE4487/2009 (human-adapted, pH1N1-WT), A/Indonesia/05/2005
(avian-adapted, H5N1-WT) and A/Anhui/1/2013 (avian-adapted, H7N9-WT). The
model contained the following processes: infection of a cell; an infected cell
entering a state of virion production; production of infectious and non-infectious
virions; infected cell death; loss of infectivity of free virions; and degradation of
free infectious and non-infectious virions (see Materials and Methods). We
estimated the rates of these processes for the four strains by fitting the model to
previously published data from single-cycle, multi-cycle and mock-yield
assays [Simon et al., 2016]. The model accurately captured key features of the
viral load (Fig. 1). With a low inoculum (MOI = 0.01), multiple generations of
infection depleted the pool of susceptible cells over a period of 6 days resulting in
an infectious viral load curve showing exponential growth, followed by a peak and
exponential decay (Fig. 1 A and D). With a larger inoculum (MOI = 3), most cells
were infected immediately and the concentration of infectious virus plateaued
earlier (Fig. 1 B and E). The loss of infectivity of free virus was captured by the
mock-yield assays where no cells were present (Fig. 1 C and F). The model was
also able to reproduce the observed total viral load patterns as quantified by
qRT-PCR, although the viral load towards the end of the single-cycle experiments
was slightly underestimated for the sH1N1-WT and pH1N1-WT strains (Fig. S1).
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Figure 1: Model fits to experimental data. The infectious viral load for the WT
strains (A-C) and the strains with PR8 HA and NA (D-F). Fitted 95% credible inter-
vals are shown as shaded areas on top the the data (triangles). The infectious viral
load is shown for (from top) the multi-cycle experiments, the single-cycle experi-
ments and the mock-yield experiments.
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Figure 2: Parameter estimates. (Top) The median and 95% credible intervals for
(A) the mean generation time, (B) basic reproduction number, and (C) initial growth
rate, for the wild-type (WT) strains (left of each panel), and the strains with PR8 HA
and NA (right). Calculation of p-values is described in the Materials and Methods.
Statistically significant pairs are labelled (α = 0.05 with Bonferroni correction for
seven pairwise tests per parameter). Asterisks denote p < 0.001. (Bottom) Contour
plots of the posterior density of the mean generation time and the basic reproduction
number for each strain, for (D) the WT strains, and (E) the strains with PR8 HA and
NA. Fainter shading indicates lower support; dots indicate median values.
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From the estimated rates of infection processes, we then calculated the basic
reproduction number, the mean generation time and the initial growth rate (the
‘cellular infection parameters’) for the four strains. We found that these parameters
differed between human-adapted and avian-adapted strains, reflecting systematic
differences in growth kinetics. We estimated the mean generation time to be
between 25 and 65 hours for the four WT strains, ranging from 32 hours (median;
95% CI 27 h–40 h) for sH1N1-WT to 55 h (median; 95% CI 42 h–65 h) for
H7N9-WT (Fig. 2A, left side of panel). There appeared to be an increasing trend
in mean generation time from the strain most adapted to humans (sH1N1-WT) to
the strain least adapted to humans (H7N9-WT). Strain differences were also
observed in the basic reproduction numbers and initial growth rates (Figs. 2B-C).
We note that combining data from three sets of experimental conditions
(multi-cycle, single-cycle and mock-yield) enabled us to estimate these parameters
accurately. Fig. S2 shows that parameter estimates using multi-cycle data only are
less precise. Data S1 shows estimated values for the rates of all the infection
processes in the model, and the correlations between them.
Fig. 2D further illustrates the observed parameter differences by showing that
human-adapted and avian-adapted strains can be separated out when the estimated
values of the basic reproduction number and the mean generation time are shown
on a two-dimensional plot. Avian-adapted strains (H5N1-WT and H7N9-WT) are
in the top right corner of this plot; the most human-adapted strain, sH1N1-WT, is
in the bottom left corner; and pH1N1-WT, which was an early pandemic strain and
possibly not completely human-adapted, is in the centre. We note the general trend
that strains with a high basic reproduction number also tend to have a long mean
generation time. The same initial growth rate can be achieved via two different
routes: a high basic reproduction number and a long mean generation time, or a
low basic reproduction number and a short mean generation
time [Nishiura et al., 2010, Wallinga and Lipsitch, 2007]. High basic reproduction
numbers and short mean generation times would lead to very high initial growth
rates, while low basic reproduction numbers and long mean generation times
would lead to very slow initial growth rates; these extreme values may not be
biologically plausible. Because the basic reproduction number and the mean
generation time are not completely independent, some types of data do not enable
independent estimation of both parameters [Nishiura et al., 2010]. This is not the
case for our data. For each strain, there is indeed some correlation in the posterior
distribution between the basic reproduction number and the mean generation time
(Fig. S3; see also the diagonally stretched posterior distributions in Fig. 2D).
Despite this correlation, there is still sufficient information in the data to separate
out estimates of both parameters for different strains (Figs. 2A-B, D).
We then investigated whether one of these three parameters alone (the basic
reproduction number, mean generation time and initial growth rate) could capture
the observed differences between strains. We found that each parameter
summarises changes in a different set of infection processes, and thus offers a
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complementary perspective on viral dynamics. Fig. S4 shows the sensitivity of
each parameter to changes in the rates of underlying infection processes, as defined
in the Materials and Methods. For example, the leftmost bar shows the percentage
change in the mean generation time for sH1N1-WT, if the infectivity of virions
βinf were changed to that of H7N9-WT. We see that the basic reproduction
number is mostly affected by changes in the mean infectious period τI and the
infectivity βinf ; the mean generation time is mostly affected by changes in τI ; and
the initial growth rate is mostly affected by changes in βinf .
We hypothesised that the differences between strains were driven by the internal
proteins. To test this hypothesis, we used reverse genetics to engineer reassortant
viruses that combined the haemagglutinin (HA) and neuraminidase (NA) segments
of A/Puerto Rico/8/34 (PR8) with the remaining six gene segments from either a
human adapted H1N1 virus (A/England/195/2009) or an avian H5N1 virus
(A/Turkey/05/2005) [Li et al., 2018]; we refer to these reassortant strains as
pH1N1-PR8 and H5N1-PR8 respectively. We conducted single-cycle, multi-cycle
and mock-yield assays for these strains, and fitted the same model to the data to
see if similar strain differences would be observed (Fig. 1D-F). The mean
generation time for H5N1-PR8 was longer than that for pH1N1-PR8 (Fig. 2A,
right side of panel). The median estimate of the basic reproduction number was
also higher for H5N1-PR8 than pH1N1-PR8, although the difference was not
statistically significant (Fig. 2B). Nevertheless, a positive correlation between
basic reproduction number and mean generation time was observed (Fig. 2E). The
initial growth rate did not appear to be different between the strains (Fig. 2C), but
the estimate for H5N1-PR8 was imprecise because few observations were made
during the exponential growth phase of the multi-cycle experiment, as the viral
load plateaued earlier than expected (Fig. 1F). Overall, the correlation between
human adaptation and lower cellular infection parameter values (a lower basic
reproduction number, shorter mean generation time and lower initial growth rate)
was consistent with our previous results. Note that we did not compare the cellular
infection parameters directly between pH1N1-WT and pH1N1-PR8, or between
H5N1-WT and H5N1-PR8, because our interest is in the difference between the
internal proteins of pH1N1 and H5N1, rather than the changes introduced to each
strain by changing their surface proteins.
Simulations using the estimated parameters showed that by the peak time of
infection, human-adapted strains compared to avian-adapted strains had a higher
proportion of virions with a large generation number, which we define as one plus
the number of replication cycles between the inoculum and the virion’s production.
The time of peak infectious viral load is of interest because in an in vivo infection,
transmission is most likely around the time of peak viral load [Carrat et al., 2008].
To perform these simulations, we extended our model to associate each infectious
virion and infected cell with a generation number (see Materials and Methods).
Fig. 3 shows the proportion of virions in each generation at the time of peak
infectious viral load, according to the maximum likelihood parameter set for each
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Figure 3: Simulated distribution of the number of virions in each generation,
for the six experimental strains. (A–B) The proportion of virions in each gen-
eration was calculated at the time of peak infectious viral load according to the
maximum likelihood parameters for each strain, for (A) the WT strains, and (B) the
strains with PR8 HA and NA. As visual aids, lines join the number of virions at
each discrete generation. (C) The mean generation number was calculated for each
sample from the joint posterior distribution for each strain. The median and 95%
credible interval for the mean generation number are shown for the WT strains (left
of each panel), and the strains with PR8 HA and NA (right). Statistically significant
pairs are labelled (α = 0.05 with Bonferroni correction for seven pairwise tests per
parameter). Asterisks denote p < 0.001.
strain, under multi-cycle experiment conditions. For these values, among the WT
strains, sH1N1-WT had a higher proportion of virions with a high generation
number compared to pH1N1-WT, H5N1-WT and H7N9-WT (Fig. 3A).
pH1N1-PR8 also had a higher proportion of virions with a high generation number
compared to H5N1-PR8 (Fig. 3B). To summarise this distribution, we calculated
the mean generation number at the time of peak infectious viral load. Calculating
this statistic across the joint posterior distribution confirmed that human-adapted
strains had a higher mean generation number compared to avian-adapted strains,
and thus virions were on average a product of more replication cycles (Fig. 3C).
We investigated the hypothesis that longer generation times alone might be driving
the difference in number of replication cycles at peak viral shedding. However, we
found that this was not the case. A sensitivity analysis showed that out of the three
parameters, changing the initial growth rate had the largest effect on the generation
number distribution at the time of peak infectious viral load (Fig. 4). When we
held the mean generation time constant (Fig. 4A), we were able to achieve very
different generation number distributions by varying the other parameters.
However, when we held the initial growth rate constant (Fig. 4C), varying the other
parameters did not substantially change the generation number distribution. Hence,
the initial growth rate was the main driver of the generation number distribution.
We conducted a number of sensitivity analyses. We tested different model
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Figure 4: Simulated distribution of the number of virions in each generation,
as cellular infection parameters are changed systematically. The proportion of
virions in each generation (the generation number distribution) was calculated at
the time of peak infection. The cellular infection parameters in the legend were
changed to the values shown. In each panel, one parameter is held constant: the
mean generation time TG (A), basic reproduction number R0 (B), or initial growth
rate r (C).
structures to see the impacts of model assumptions on estimated parameter values.
First, we ignored loss of free virions due to entry into target cells (Supporting
Text). These changes only changed estimated parameter values slightly, and did
not affect the relationship between the cellular infection parameters, human
adaptation, and the generation number distribution (Fig. S5). Second, we
decreased the level of heterogeneity in the generation time. We first decreased
heterogeneity by narrowing the distribution of the latent period and duration of
virion production, by setting nL = nI = 60 in the model equations. This change
also did not affect the above relationships (Fig. S6).
We then decreased heterogeneity by changing the timing of production of virions.
In the model in the main text, once each cell starts producing virus, it does so at a
constant rate until death. (Note that due to heterogeneity in infected cells’
lifetimes, the bulk production rate of virions by many cells varies over time.) On
the other hand, models including intracellular processes predict an age-dependent
production rate [Heldt et al., 2013]. Fig. S7 shows the viral load estimated using a
model where the production rate of virions increases over an infectious cell’s age
of infection (Supporting Text). In this model, most virions are produced toward the
end of an infected cell’s lifespan, so there is less heterogeneity in the generation
time. This model predicts slightly different dynamics from the model in the main
text (Fig. 1). For the multi-cycle data, the new model predicts a sharp increase in
viral load followed by a sharp decline for all strains. The model in the main text
predicted similar dynamics for human-adapted strains, but a gradual plateau in
viral load followed by a decrease for avian-adapted strains. This difference can be
seen by inspection of the data, and is missed by the new model. For the
single-cycle data, the new model produces ”bumpy” curves with multiple stages of
rapid viral growth, whereas the model in the main text produces the sigmoidal
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curves characteristic of single-cycle growth kinetics. Model predictions of the
mock-yield viral load have a different slope from the data, particularly for
H5N1-PR8. We hypothesise that in the new model, the slope of the multi-cycle
viral load during its decay phase is less driven by the infected cell lifespan and
more driven by the loss of virus infectivity; hence, the new model is unable to
explain strain differences in the multi-cycle viral load decay rate without
introducing artificial differences in the rate of loss of virus infectivity. Due to these
qualitative differences between the data and the estimated viral load, we conclude
that the model in the main text, where the production rate is constant, is more
appropriate.
Last, we removed heterogeneity in the generation time altogether, which we
hypothesised would change the relationship between the cellular infection
parameters and the number of replication cycles by the time of peak infectious viral
load. We conducted this sensitivity analysis because evolutionary models often
assume a fixed generation time, such that at a given time all virions belong to the
same generation [Russell et al., 2012, Geoghegan et al., 2016, Illingworth, 2015].
Fig. S8 shows the simulated generation number of virions at the time of peak
infectious viral load for a model with a fixed generation time; details are given in
Supporting Text. When we held the basic reproduction number constant
(Fig. S8B), varying the other parameters did not change the generation number,
whereas when we held the generation time or the initial growth rate constant, we
were able to change the generation number by varying the other parameters.
Hence, for the fixed generation time model, only the basic reproduction number
influences the generation number at the time of peak viral load. This drastically
different result implies that quantitative predictions of the number of mutations
accumulated during the time course of infection should account for heterogeneity
in the generation time. This heterogeneity arises because virions are produced
throughout the infectious period of a cell, and the infected cell lifespan is itself
highly heterogeneous [Holder and Beauchemin, 2011, Beauchemin et al., 2017].
These sources of heterogeneity are reflected in our model structure, and lead to
successive generations of virions overlapping in time rather than all virions
belonging to the same generation.
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Discussion
In this study, we quantified in vitro parameters — the basic reproduction number,
the mean generation time, and the initial growth rate — for six influenza strains
using a mechanistic model. Avian-adapted strains had higher initial growth rates
compared to human-adapted strains, which can be directly seen in the data. They
were also estimated to have higher basic reproduction numbers and longer mean
generation times. We found that these differences were driven by differences in
internal proteins, suggesting a role for experiments to measure these parameters in
assessing pandemic risk due to adaptation of internal proteins.
The main limitation of of our results with respect to this finding is that we have
only assessed these parameters in six strains, three with human-adapted internal
genes and three with avian-adapted internal genes. We note that experiments for
one human-adapted strain (pH1N1-PR8) and one avian adapted strain (H5N1-PR8)
were designed specifically to measure these parameters and test the hypotheses
generated using data from the other strains. Nonetheless, to strengthen the case for
the the utility of these parameters, it would be desirable to repeat these
experiments for a wider panel of strains with the same surface proteins, to see
whether differences in cellular infection parameters still hold across more
human-adapted and avian-adapted strains. A positive result would strengthen the
case for the routine use of these assays to assess pandemic risk.
The strength of comparing strains engineered to have the same surface proteins is
that we could observe differences due to internal proteins which may otherwise
have been obscured by receptor binding differences. Differences in internal
proteins are likely to generalise across cell types and to conditions in epithelial
cells lining the respiratory tract. Differences in surface proteins, such as those
which affect receptor binding, are more likely to be cell-type specific. Hence, if
considering the combined effect of internal and surface proteins in wild-type
strains, experimental conditions would need to more closely mimic conditions in
the respiratory tract, for example by using primary differentiated human epithelial
cells rather than the A549 cell line. We caution that the observed differences in
reproduction number, generation time and growth rate due to internal protein
adaptation need to be considered together with surface protein adaptations for
comprehensive pandemic risk assessment. For example, a previous study used
primary normal human bronchial epithelial cells as a model of the respiratory tract,
and found that higher, not lower, basic reproduction numbers were associated with
human adaptation [Mitchell et al., 2011]. Although this result appears to contradict
our findings, higher basic reproduction numbers for human-adapted strains in
primary normal human bronchial epithelial cells were likely due to strain
differences in receptor binding specificity, since these cells primarily express
α2,6-linked sialic acid receptors which are already well understood to be favoured
by human-adapted strains. In our experiments where strains were engineered to
have the same surface proteins, we could eliminate the already-known effects of
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receptor binding and isolate the effect of differences in internal proteins.
We suggest the growth rate, the basic reproductive number, and the generation time
taken together may form a useful description of influenza strain growth dynamics
in the absence of immunity. Uncovering the mechanisms leading to the observed
differences may lead to increased understanding of the biology of host species
jumps. Intuitively, one may expect that increasing the growth rate through both
increasing the reproduction number and shortening the generation time would give
the greatest evolutionary advantage; instead, human adaptation favours a shorter
generation time but also a smaller cellular reproduction number. This result
suggests a potential trade-off between reproduction number and generation time
that may enable different replication strategies in the human respiratory tract and
the avian gastrointestinal tract, the primary sites of infection for human and avian
infection respectively. The human respiratory tract may elicit a stronger local
immune response, favouring strains which can reproduce quickly and release new
virions which spread and evade the local response. The conditions for free virion
survival are different in the avian gastrointestinal tract, which could favour a higher
reproduction number to maximise the contribution of each infectious cell to
onwards replications.
As reviewed by Wargo et al. [Wargo and Kurath, 2012], virological data analysis
protocols have mostly used the initial growth rate to measure in vitro fitness,
interpreting a larger growth rate as a fitness advantage. The previous analysis of
four of the strains presented here by Simon et al. [Simon et al., 2016] showed
strain differences in the rate of infection, which is closely related to the initial
growth rate. A limited number of studies have computed the basic reproduction
number, and fewer still have compared it between virus
strains [Mitchell et al., 2011, Iwanami et al., 2017, Farrukee et al., 2018]. Some
modelling studies have computed another related quantity, the infecting time,
which is the time between a cell starting to produce virus and infection of the first
secondary cell [Pinky and Dobrovolny, 2016, Paradis et al., 2015,
Holder et al., 2011, Holder and Beauchemin, 2011, Pinilla et al., 2012,
Petrie et al., 2013, Petrie et al., 2015, Gonza`lez-Parra et al., 2018]. The mean
generation time differs from the infecting time because the mean generation time is
averaged over all secondary cells, and also includes the period before an infected
cell starts producing virus. If cell and virion loss are assumed to be negligible
during early infection, then the initial growth rate is inversely proportional to the
sum of the infecting time and the latent period before an infected cell produces
virus.
In our study, we showed that a lower basic reproduction number, a shorter mean
generation time and a slower initial growth rate are associated with human
adaptation. However, we also showed that strain differences in the three cellular
infection parameters were driven by changes in rates of different underlying
infection processes, such that each parameter provides a different perspective.
Some studies have directly compared the rates of these infection processes for
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strains differing by a single mutation [Pinilla et al., 2012, Holder et al., 2011,
Petrie et al., 2015, Simon et al., 2016]. Because mutations may affect one of more
infection processes, combining these processes into a smaller number of summary
measures — the basic reproduction number, mean generation time, and initial
growth rate — may enable easier between-strain comparisons.
We also found that strains with lower initial growth rates have a higher proportion
of virions which are a product of a large number of replication cycles at the time of
peak infection, when transmission is most likely to occur for the in vivo case. For a
given mutation rate per replication cycle (as estimated by Parvin et
al. [Parvin et al., 1986] and Nobusawa et al. [Nobusawa and Sato, 2006]), this
implies quicker accumulation of mutations. The degree of heterogeneity in the
generation time also changed the generation number distribution. If we
unrealistically assumed no heterogeneity in the generation time, then the
generation number at the time of peak viral load depended entirely on the basic
reproduction number rather than the initial growth rate, highlighting the
importance of heterogeneity in the generation time in evolutionary models.
A caveat of this second finding is that the relationship between the generation
number distribution and the initial growth rate would be different in vivo due to a
time-dependent immune response. However, the overall finding that different
cellular infection parameter values lead to different generation number
distributions at a given time should still hold. Also, in linking the accumulation of
generations to accumulation of mutations, we have assumed that the number of
errors introduced between primary and secondary virions is independent of when
the secondary virion was produced during the infected cell’s lifespan. However,
the number of errors introduced may increase with the age of the infected cell,
since a virion exiting an ‘older’ cell may have been a product of more intracellular
replication and transcription cycles than a virion exiting a ‘younger’ cell. In our
model, we have not considered multiple intracellular replication and transcription
cycles before virus release. However, the relationship between a cell’s age and the
number of mutations in produced virions is yet to be well understood.
Materials and Methods
Strains with wild-type HA and NA
In brief, A/Canada/RV733/2003, A/Mexico/INDRE4487/2009,
A/Indonesia/05/2005 and A/Anhui/1/2013 stocks were grown in MDCK cells.
Single-cycle and multi-cycle experiments were carried out in triplicate in A549
human lung carcinoma cells in T25 flasks. Cells were infected at MOI = 3 and
MOI = 0.01 for the single-cycle and multi-cycle experiments respectively, for an
incubation period of 1 hour at 37◦C. For the single-cycle experiment, the cells
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were washed with an acidic saline wash after the incubation period. At set time
points, 0.5 mL of the 10 mL supernatant volume was harvested and replaced with
0.5 mL of fresh media. A mock-yield experiment was also performed in triplicate,
where 107 pfu of each strain was left to decay in cell-free media incubated at 37◦C.
Infectious virus was quantified using a TCID50 assay, and for the single-cycle and
multi-cycle experiments, total virus was quantified using qRT-PCR. See Simon et
al. [Simon et al., 2016] for the full protocol.
Strains with PR8 HA and NA
Human embryonic kidney (293T) (ATCC), human lung adenocarcinoma epithelial
cells (A549) (ATCC) and Madin-Darby canine kidney (MDCK) cells (ATCC) cells
were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
Invitrogen) supplemented with 10% fetal calf serum, 1% non-essential amino acids
and 1% penicillin-streptomycin (5000 IU/mL; 5000 µL) at 37◦C and 5% CO2.
We generated two reverse genetics viruses (pH1N1-PR8 and H5N1-PR8). In these
viruses, the HA and NA genes were from the laboratory adapted strain A/Puerto
Rico/8/34 (H1N1), and the six remaining gene segments were from either
A/England/195/2009 (pH1N1) or A/Turkey/05/2005 (H5N1). Eight poll plasmids
encoding the indicated virus segments and four helper expression plasmids
encoding polymerase components and NP expressed by the pCAGGS vector were
transfected into 293T cells. After 24 hours, the transfected 293T cells were
resuspended and co-cultured with MDCK cells. Virus stocks were thus grown on
MDCK cells using serum free DMEM supplemented with 1µg/mL of TPCK
trypsin (Worthington). Viruses were stored in -80◦C and titrated on MDCK cells
by plaque assay to determine the dilution required to achieve a given multiplicity
of infection.
All infection experiments were performed in triplicate (three wells on the same
plate). For the single-cycle and multi-cycle experiments, A549 cells were plated in
a six-well plate (2.5× 106 cells per well). One day after plating, medium was
removed from cells and cells were washed twice with PBS (3 mL/well), then
covered with 500 µL serum-free DMEM medium. Cells were infected at MOI = 5
and MOI = 0.01 for the single-cycle and multi-cycle experiments respectively; the
virus was thawed in a 37 ◦C water bath, then diluted with serum-free DMEM to a
volume of 500 µL. After an incubation period of one hour, the inoculum was
removed, cells were washed four times with 3 mL serum-free DMEM, and 3 mL
serum-free DMEM with 1 µg/mL TPCK-treated trypsin was added to each well
(without cells). At each measurement time (shown in Fig. 1), the plates were
shaken and 300 µL supernatant was collected, and replaced by 300 µL serum-free
DMEM with 1 µg/mL TPCK-treated trypsin. The supernatant was frozen at -80◦C
for later quantification. For the mock-yield experiments, 3 mL of virus at
concentration 107 pfu/mL was added to each well. At each measurement time, 300
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µL supernatant was collected without replacement and frozen at -80◦C for later
quantification.
Plaque assays were carried out in confluent monolayers of MDCK cells in 12-well
plates. 100 µL of each tenfold virus dilution was applied to each cell and incubated
for 1 hour at 37◦C. The inoculum was then removed, and the cells were overlaid
with 0.6% agarose in MEM including 1 µg/mL TPCK-treated trypsin and 0.3%
bovine serum albumin fraction V (Gibco). The cells were then incubated at 37◦C.
After 3 days, the agarose was removed and the cells stained with 1 mL 0.5%
crystal violet.
Mathematical model
A
B
Figure 5: (A) Viral dynamics model; (B) Model tracking generation num-
ber. Circles indicate cell compartments, while squares denote virion compartments.
Quotation marks indicate that the waiting time between compartments is gamma-
distributed rather than exponentially distributed, and that the mean waiting time is
the inverse of the ‘rate’ given. (B) illustrates N = 3 generations.
Our mechanistic model (Fig. 5) included the following processes:
• infection of a cell at rate βinf ;
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• an infected cell entering a state of virion production (τL is the mean time
spent in the latent period between infection and the state of virion
production);
• production of infectious and non-infectious virions at rates pinf and pRNA
respectively;
• infected cell death (τI is the mean time from entering the state of virion
production to death);
• loss of infectivity of free infectious virions at rate cinf ; and
• degradation of free infectious and non-infectious virions at rate cRNA.
This model was adapted from that used by Simon et al. [Simon et al., 2016]. We
did not model time-dependent effects of the immune response. The model is
formulated as a set of ordinary differential equations, as shown in the Supporting
Text.
Single-cycle, multi-cycle and mock-yield experiments can be simulated using this
model by changing the initial conditions. Single-cycle and multi-cycle
experiments start with a fixed number of target cells T0, and infectious and total
virus at a low MOI (multi-cycle) or a high MOI (single-cycle). Mock-yield
experiments start with no target cells and a large amount of infectious virus.
The cellular infection parameters were expressed as functions of the rates of
infection processes. The basic reproduction number is
R0 =
βinfT0pinfτI
c+ βinfT0
; (1)
the mean generation time, which we consider in the context of a fully susceptible
population, is
τG = τL +
nI + 1
2nI
τI +
1
c+ βinfT0
; (2)
and the initial growth rate r is computed by linearising around the disease-free
equilibrium [T, Li, Ii, Vinf ] = [T0, 0, 0, 0] [Nowak et al., 1997, Lee et al., 2009].
To relate the data to the viral load predicted by the model, we introduced
parameters to convert the number of infectious and total virions to the
concentration of infectious and total virus measured in the supernatant. We then
modelled observation error as lognormal, with an observation threshold at low
titres.
18
Parameter estimation
Parameters were estimated for each strain separately using an adaptive
Metropolis-Hastings algorithm. For a given strain, parameters were estimated
using combined data from the multi-cycle, single-cycle and mock yield
experiments. For a given strain, these experiments share all model parameters
except for the production rate of infectious virus pinf , and otherwise differ only in
initial conditions. pinf for the single-cycle experiments is modelled as lower (or
equal to) that for the multi-cycle experiments, to account for decreased infectious
viral production due to the presence of defective interfering particles at a high
multiplicity of infection [Simon et al., 2016].
The viral RNA degradation rate, shape parameters of the latent period and viral
production period distributions, initial number of target cells, supernatant volume
and observation threshold were fixed. All other parameter values, including initial
conditions, were estimated. A multi-dimensional uniform distribution was used as
the prior, with some parameters log-transformed. Tables showing the fixed
parameter values and the priors for the estimated parameters are included in the
Supporting Text.
Statistical analysis
For each pair of viruses in the study, for each estimated parameter, we computed
the ratio of the virus-specific parameter values, and tested for deviations of the
ratio from 1. For each parameter, p-values for each virus pair were computed by
sampling with replacement from each marginal posterior distribution, and letting q
be the proportion of sampled pairs whose ratio exceeds 1. The p-value was then
p = 2(min(q, 1− q)). The strains with wild-type HA and NA were only compared
to each other, and not to the strains with PR8 HA and NA.
Model with generation numbers
We extended our model to explicitly associate each virion and infected cell with a
generation number. The inoculum was denoted virus generation 1, the cells
infected by the inoculum denoted cell generation 1, the infectious virions produced
by those cells denoted virus generation 2, and so forth. This model enables us to
calculate the proportion of virions from each generation at a given time. The
model with generations is illustrated in Fig. 5B for tracking N = 3 generations;
the actual implementation tracks 20 generations. (Cells and virions above
generation N are lumped into the generation N compartments). The bulk
dynamics of the model remain the same, that is, the number of cells in L in Fig. 5A
is equal to the sum of the numbers of cells in L1, L2 and L3 in Fig. 5B, and
similarly for I and Vinf . Model equations are in the Supporting Text.
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Data and code to reproduce all results can be found at
https://github.com/ada-w-yan/cellularfluparams.
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Details of mathematical model
Model in units of virions
The model equations are based off those in the study by Simon et
al. [Simon et al., 2016] with modifications to account for loss of virus due to entry
into target cells [Handel et al., 2007]. The model structure was first used by
Perelson et al. [Perelson et al., 1996] to model HIV infection, and first applied to
influenza infection by Baccam et al. [Baccam et al., 2006]. Target cells (uninfected
cells) (T ) are infected by free virus (Vinf ) according to a mass-action term with
rate βinf . The newly infected cells (L) enter a latent period before they can
produce free virus. At the end of the latent period, the cells transition from the L to
the I stage, and the infectious cells produce free virus at a constant rate pinf . Free
virus decays at a constant rate c, and infectious cell lifespans are Erlang-distributed
with mean τI and shape parameter nI .
dT
dt
= −βinfTVinf , (1a)
dL1
dt
= βinfTVinf − nL
τL
L1, (1b)
dLi
dt
=
nL
τL
(Li−1 − Li), (1c)
dI1
dt
=
nL
τL
Li − nI
τI
I1, (1d)
dIi
dt
=
nI
τI
(Ii−1 − Ii), (1e)
dVinf
dt
= pinf
nI∑
i=1
Ii − cVinf − βinfTVinf (1f)
Parameter Definition Units
c Free virus decay rate h−1
βinf Rate at which cells are infected by virus infectious unit −1 h−1
τL Mean latent period h
τI Mean infectious period h
pinf Rate at which virus is produced by infected cells infectious unit (cell−1) h−1
nL Number of latent stages -
nI Number of infectious stages -
The model can be written as a set of ordinary differential equations (Eq. 1). In
Eq. 1, Vinf is in infectious units, which we define as the amount of free virus lost
from the medium to infect a single cell. We will shortly derive equations to link
Vinf to experimentally measured units. The infected cells pass through nL latent
2
stages and nI infectious stages, where the duration of each stage is exponentially
distributed. As a result, the latent and infectious periods are Erlang distributed.
Holder et al. [Holder and Beauchemin, 2011] showed that for influenza, compared
to exponentially distributed latent and infectious periods, normally distributed or
lognormally distributed latent and infectious periods lead to better fits to
single-cycle data. When the shape parameter is much greater than 1, the Erlang
distribution is similar in shape to the normal and lognormal distributions. The
Erlang distribution was also used in influenza viral dynamics
models [Pinilla et al., 2012, Beggs and Dobrovolny, 2015, Petrie et al., 2013,
Liao et al., 2016, Paradis et al., 2015], and in HIV viral dynamics
models [Beauchemin et al., 2017].
Linking model to experimentally observed quantities
To link our model to observed experimental quantities, we make two modifications.
In Eq. 1, Vinf is in infectious units, which we define as the amount of free virus lost
from the medium to infect a single cell. However, for the strains with PR8 HA and
NA, we observe the number of plaque forming units (pfu) per mL of supernatant.
We define n to be the number of infectious units per pfu, where n ≥ 1, and S to be
the supernatant volume. Then we can make the following unit conversions:
Vpfu =
Vinf
n
, (2a)
Vpfu/mL =
Vinf
nS
, (2b)
βpfu/mL = βinfnS, (2c)
ppfu/mL =
pinf
nS
, (2d)
3
to arrive at the model equations in observation units:
dT
dt
= −βpfu/mLTVpfu/mL, (3a)
dL1
dt
= βpfu/mLTVpfu/mL − nL
τL
L1, (3b)
dLi
dt
=
nL
τL
(Li−1 − Li), (3c)
dI1
dt
=
nL
τL
Li − nI
τI
I1, (3d)
dIi
dt
=
nI
τI
(Ii−1 − Ii), (3e)
dVpfu/mL
dt
= ppfu/mL
nI∑
i=1
Ii − cVpfu/mL − βinfTVpfu/mL. (3f)
Parameter Definition Units
βpfu/mL Rate at which cells are infected by virus (pfu/mL)−1 h−1
ppfu/mL Rate at which virus is produced by infected cells (pfu/mL) (cell−1) h−1
n Number of infectious units per pfu infectious unit (pfu)−1
S Supernatant volume mL
For the strains with wild-type HA and NA, we observe the number of TCID50s per
mL of supernatant. We use the same equations where n is now the number of
TCID50 per infectious unit, where n ≥ 1.
For the strains with wild-type HA and NA, the total free viral load (in RNA copy
number/mL) was measured in addition to the infectious viral load. The total viral
load differs from the infectious viral load because an infected cell produces both
infectious and non-infectious virions, the latter of which arise due to defects
introduced during the viral replication
process [Nayak et al., 1985, Marriott and Dimmock, 2010]. It had previously been
shown that fitting a model to the infectious and total viral load improves parameter
estimates compared to fitting to infectious viral load only [Petrie et al., 2013], and
several other studies have fitted models including the total viral load to
data [Pinilla et al., 2012, Paradis et al., 2015, Beggs and Dobrovolny, 2015]. We
model production of total virus (VRNA) by infectious cells (I) at a constant rate
pRNA. Total virus decays at a constant rate cRNA, and is also lost due to entry into
target cells. We assume that one infectious unit contributes one copy number to the
total viral load [Yan et al., 2019]. The equation for the total viral load
concentration (VRNA/mL) is then
dVRNA/mL
dt
= pRNA/mL
nI∑
i=1
Ii − cRNAVRNA/mL − βinfnTVpfu/mL. (4)
4
For the multi-cycle experiments with wild-type HA and NA, infection begins with
the addition of virus to target cells and medium at t = 0. The initial conditions are
then T (0) = T0, VMC,TCID50/mL(0) = VMC,TCID50/mL,0,
VMC,RNA/mL(0) = VMC,RNA/mL,0 for the strains with wild-type HA and NA. The
initial values of all other compartments are 0.
For the single-cycle experiments, and for the multi-cycle experiments with PR8
HA and NA, the virus was incubated for an hour, then the cells were washed and
the medium replaced. For the strains with PR8 HA and NA, we model this by
setting T (−1) = T0, Vpfu/mL(−1) = Vpfu/mL,−1, and all other compartments to
zero. We then solve Eq. 3 from t = −1 to t = 0, set Vpfu/mL(0) = Vpfu/mL,0, then
continue solving the equations until the end of the experiment. For these
experiments, all reported times are times post-washing. The strains with wild-type
HA and NA are modelled in the same way, but in units of TCID50/mL, and with
the addition of Eq. 4.
For the mock-yield experiments, the initial conditions are
Vmock,pfu/mL(0) = Vmock,pfu/mL,0 for the strains with PR8 HA and NA, and
Vmock,TCID50/mL(0) = Vmock,TCID50/mL,0 for the strains with wild-type HA and
NA (total virus was not measured for these experiments). The initial values of all
other compartments are 0.
Model equations are solved using the odin package version 0.1.1, available at
https://github.com/mrc-ide/odin.
We model the observed viral load (infectious or total) as lognormally distributed
around the true viral load. For example, for a single data point for the total viral
load in a multi-cycle experiment, we have
P (VˆMC,RNA/mL(t)|θ) = 1√
2σ2RNApi
exp
−
[
log10 VˆMC,RNA/mL(t)− log10 VMC,RNA/mL(t,θ)
]2
2σ2RNA

(5)
where VˆMC,RNA/mL(t) is the observed viral load at time t and VMC,RNA/mL(t,θ) is
the true viral load at time t according to the model parameters θ.
In addition, for the plaque assay we model an observation threshold of Θ = 10
pfu/mL below which the viral load is treated as censored [Yan et al., 2019]. We
denote below-threshold measurements as 0, so Vˆpfu/mL(t) can take the value 0 or
any value above (and including) Θ. The likelihood of a single data point according
5
to the plaque assay given model parameters is then given by Eq. 6.
P (Vˆpfu/mL(t)|θ) =

1√
2σ2pfupi
exp
{
− [log10 Vˆpfu/mL(t)−log10 Vpfu/mL(t,θ)]
2
2σ2pfu
}
if Vˆpfu/mL(t) ≥ Θ,∫
Θ
0
1√
2σ2pi
exp
{
− [log10 x−log10 Vpfu/mL(t,θ)]
2
2σ2
}
dx if Vˆpfu/mL(t) = 0,
0 otherwise.
(6a)
Errors are assumed to be independent, so the likelihood across all data points is
the product of the likelihoods of each of the data points.
Model fitting
The values of fixed model parameters are as follows.
Parameter Value Units
cRNA 10
−3 h−1
nL 10 -
nI 10 -
T0 10
6 (WT) or 2.5× 106 (PR8) cell
S 10 (WT) or 3 (PR8) mL
Θ 0 or 10 pfu mL−1
The prior bounds for fitted parameters are as follows. Parameters with Y in the log
transform column have uniform priors in log space, while the others have uniform
priors in linear space. Priors are the same for the strains with wild-type HA and
NA and the strains with PR8 HA and NA, except the units for infectious virus are
pfu and TCID50 respectively. Also, the incubation period is absent for the
multi-cycle experiments with wild-type HA and NA, so VMC,TCID50/mL,−1 is fixed
at 0 for these strains.
6
Parameter log transform Prior bounds Units
c Y [10−3, 100] h−1
βinf Y [10−10, 10−1] infectious unit −1 h−1
τL N [0.1, 12] h
τI Y [100, 103] h
pSC,pfu/mL/pMC,pfu/mL Y [10−5, 100] -
pMC,pfu/mL Y [10−2, 103] pfu mL−1 cell−1 h−1
pRNA/mL Y [100, 106] copy number mL−1 cell−1 h−1
n Y [100, 107] infectious unit pfu−1
VSC,pfu/mL,−1 Y [100, 10
10T0
S
] pfu mL−1
VSC,pfu/mL,0 Y [10−2, 107] pfu mL−1
VSC,RNA/mL,0/VSC,pfu/mL,0 Y [100, 106] copy number pfu−1
VMC,pfu/mL,−1 Y [100, T010S ] pfu mL
−1
VMC,pfu/mL,0 Y [10−2, 104] pfu mL−1
VMC,RNA/mL,0/VMC,pfu/mL,0 Y [100, 106] copy number pfu−1
Vmock,pfu/mL,0 Y [105, 1010] pfu mL−1
σpfu N [0, 2] pfu mL−1
σRNA N [0, 2] copy number mL−1
The joint posterior distribution of model parameters is obtained using an adaptive
Metropolis-Hastings algorithm, which we implemented in R version 3.4.4as the
package lazymcmc, available at
https://github.com/ada-w-yan/lazymcmc/. Parallel tempering (as
developed by Geyer et al. [Geyer, 1991] and reviewed by Earl2005 et
al. [Earl and Deem, 2005]) was implemented to improve exploration of parameter
space. Five parallel chains with different temperatures were used; the temperatures
were calibrated as previously described in Yan et al. [Yan et al., 2019]. To assess
convergence, three such sets of five parallel chains were run, after which
convergence was assessed using the coda package version
0.19-1 [Plummer et al., 2006], as previously described in Yan et
al. [Yan et al., 2019].
Code to reproduce all results can be found at
https://github.com/ada-w-yan/cellularfluparams.
Calculation of the proportion of infectious virions in
each generation
To calculate the proportion of infectious virions in each generation, we modify
Eq. 3 to track the generation number of latent cells, infectious cells and infectious
7
virions.
dT
dt
= −βT
G∑
g=1
Vpfu/mL,g, (7a)
dL1,g
dt
= βTVpfu/mL,g − nL
τL
L1,g, g = 1, . . . , G, (7b)
dLi,g
dt
=
nL
τL
(Li−1,g − Li,g), g = 1, . . . , G, (7c)
dI1,g
dt
=
nL
τL
Li,g − nI
τI
I1,g, = 1, . . . , G, (7d)
dIi,g
dt
=
nI
τI
(Ii−1,g − Ii,g), g = 1, . . . , G, (7e)
dVpfu/mL, 1
dt
= −cVpfu/mL,1 − βinfTVpfu/mL,1, (7f)
dVpfu/mL, g
dt
= p
nI∑
i=1
Ii,g−1 − cVpfu/mL,g
− βinfTVpfu/mL,g, g = 2, . . . , G− 1, (7g)
dVpfu/mL, G
dt
= p
nI∑
i=1
(Ii,G−1 + Ii,G)− cVpfu/mL,G
− βinfTVpfu/mL,G. (7h)
Here, g denotes the generation number, and G is the maximum number of
generations tracked, which is capped for computational purposes at G = 20. The
inoculum is defined as the first generation of virions, which infect cells to produce
first-generation latent cells, which become first-generation infectious cells, which
produce second-generation virions, and so forth. We solve the equations for the
maximum likelihood parameters for a given strain, using multi-cycle initial
conditions, to determine the peak viral load and infectious virion distribution at
that time.
Varying cellular infection parameters systematically
for the generation number model
To create Fig. 4, first, the cellular generation time (TG) was held constant while the
cellular reproduction number (R0) and the initial growth rate (r) were increased by
increasing pinf,MC , the production rate of infectious virions for a multi-cycle
experiment. Second, R0 was held constant while TG was increased and r was
decreased. This was accomplished by increasing the infectious cell lifespan τI and
8
decreasing pinf,MC simultaneously to hold the burst size pinf,MCτI constant. Third,
r was held constant while R0 and TG were increased. This was accomplished by
increasing the infectious cell lifespan τI and calculating the value of pinf,MC to
keep r constant. The value of pinf,MC with the desired value of r was found using
the uniroot function in R version 3.4.4.
Fixed generation distribution
To create Fig. S8, we simulated from the model by Russell et
al. [Russell et al., 2012], where one starts with an initial number of virions, and at
fixed intervals (the generation time), each virion produces R0 secondary virions
and the original virions are discarded, advancing the model by one generation. In
this model, the viral load is capped at Vmax = 1014 virions. Starting from one
initial virion, we simulate viral growth until the viral load reaches Vmax, at which
we declare the peak is reached and record the number of generations taken to get
there. For this model, the relationship between the cellular reproduction number
R0, the cellular generation time TG and the initial growth rate r is
R0 = exp(rTG). (8)
First, we held TG constant at 12 h while varying R0 between 103 and 106,
calculating the corresponding value of r using Eq. 8. Then, we held R0 constant at
104 while varying TG between 6 and 24 h, calculating the corresponding value of r
using Eq. 8. Last, we held r constant at 1 while varying TG between 6 and 24 h,
calculating the corresponding value of R0 using Eq. 8.
Model ignoring the loss of virus due to entry into
target cells
To ignore the loss of virus due to entry into target cells, we modify Eq. 3 by setting
βinf to 0. We decouple the relationship between βinf and βpfu/mL, and fit βpfu/mL
directly. The prior bounds for βpfu/mL are [10−10, 10−1].
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Model where the production rate of virions increases
over an infectious cell’s age of infection
We modify Eq. 3 such that the production rate of virions depends on the age of the
infectious cell:
dT
dt
= −βpfu/mLTVpfu/mL, (9a)
dL1
dt
= βpfu/mLTVpfu/mL − nL
τL
L1, (9b)
dLi
dt
=
nL
τL
(Li−1 − Li), (9c)
dI1
dt
=
nL
τL
Li − nI
τI
I1, (9d)
dIi
dt
=
nI
τI
(Ii−1 − Ii), (9e)
dVpfu/mL
dt
=
nI∑
i=1
i
nI
ppfu/mL,maxIi − cVpfu/mL − βinfTVpfu/mL, (9f)
dVRNA/mL
dt
=
nI∑
i=1
i
nI
pRNA/mL,maxIi − cRNAVRNA/mL − βinfnTVpfu/mL. (9g)
We fit pMC,pfu/mL,max and pRNA/mL,max using the prior bounds [10−2, 1010] and
[100, 1010] respectively. As per the model in the main text, we assume that the
maximum infectious virion production rate for the single-cycle experiment is
lower or equal to that of the multi-cycle experiment, and fit
pSC,pfu/mL,max/pMC,pfu/mL,max with prior bounds [10−5, 100].
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Supporting Figures
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Figure S1: The total viral load for the strains with wild-type HA and NA. Fitted
95% credible intervals are shown as shaded areas on top the the data (triangles).
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Figure S2: Parameter estimates using the multi-cycle data only. The median and
95% credible intervals for (A) the mean generation time, (B) cellular reproduction
number, and (C) initial growth rate, for the WT strains (left of each panel), and the
strains with PR8 HA and NA (right). Asterisks denote p < 0.001.
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Figure S3: Left three columns: Posterior distributions for (left to right) the mean
generation time TG, the basic reproduction number R0, and the initial growth rate r.
Right columns: joint posterior density of R0 versus TG, r versus R0, and r versus
TG.
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Figure S4: Percentage change in the cellular infection parameters — basic
reproduction number, mean generation time and initial growth rate — for
sH1N1-WT, changing the value of the parameter in the horizontal axis to that
of H7N9-WT. The baseline parameters are sampled from the joint posterior distri-
bution for sH1N1-WT. As a sensitivity analysis, we change the rates of infection
processes in the model one by one to rates sampled from the joint posterior distri-
bution for H7N9-WT, to determine each rate’s influence on the value of the cellular
infection parameters. These rates are changed by changing βinf , the infectivity of
virions; cinf , the rate at which virions lose infectivity; pinf,MC , the production rate
of infectious virions in the multi-cycle experiment; τI , the mean infectious period;
and τL, the mean latent period (as defined in the model equations). For example, the
leftmost bar shows the percentage change in the mean generation time for sH1N1-
WT, if the infectivity of virions βinf were changed to that of H7N9-WT. The value
of this bar is determined by calculating the mean generation time for sH1N1-WT;
taking the rates of infection processes for sH1N1-WT, and replacing the infectivity
βinf with the value for H7N9-WT; re-calculating the mean generation time; and
finding the percentage change between the two mean generation time values. This
process is repeated for many pairs of samples from the joint posterior distributions
for sH1N1-WT and H7N9-WT, to obtain the median and 95% credible intervals
plotted here.
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Figure S5: Parameter estimates and correlations for a model ignoring loss of
free virions due to entry into target cells. The median and 95% credible intervals
for (A) the mean generation time, (B) basic reproduction number, (C) initial growth
rate and (D) mean generation number, for the WT strains (left of each panel), and the
strains with PR8 HA and NA (right). Statistically significant pairs are labelled (α =
0.05 with Bonferroni correction for seven pairwise tests per parameter). Asterisks
denote p < 0.001.
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Figure S6: Parameter estimates and correlations for a narrower distribution
of the latent period and duration of virion production, setting nL = nI = 60
in the model equations. The median and 95% credible intervals for (A) the mean
generation time, (B) basic reproduction number, (C) initial growth rate and (D)
mean generation number, for the WT strains (left of each panel), and the strains
with PR8 HA and NA (right). Statistically significant pairs are labelled (α = 0.05
with Bonferroni correction for seven pairwise tests per parameter). Asterisks denote
p < 0.001.
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Figure S7: Model with linearly increasing production rate: fits to experimental
data. The infectious viral load for the WT strains (A-C) and the strains with PR8
HA and NA (D-F). Fitted 95% credible intervals are shown as shaded areas on top
the the data (triangles). The infectious viral load is shown for (from top) the multi-
cycle experiments, the single-cycle experiments and the mock-yield experiments.
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Figure S8: Simulated generation number of virions, as cellular infection pa-
rameters are changed systematically, for a model with synchronised genera-
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